This AI-generated translation is currently being refined.
IPRAFEINE is used for the short-term symptomatic treatment of moderate acute pain, such as toothaches or headaches. IPRAFEINE is indicated for use in adults only.
Medicine
Ipraféine 400 mg of ibuprofen/100 mg of caffeine, Acute moderate pain, For adults only, box of 12 film-coated tablets
1 box of 12 film-coated tablets
5,95€
In stockThis is a medicine. Information on precautions for use (drug interactions, contraindications, special warnings, adverse reactions...) and dosage are detailed in the summary of product characteristics.
In accordance with current regulations, any suspected adverse effect of a medication must be reported: Een bijwerking melden. .
This medication is intended for adults over 18 years of age. Read the package insert carefully before use.
For moderate acute pain, the recommended dosage is 1 IPRAFEINE tablet (400 mg of ibuprofen and 100 mg of caffeine).
If necessary, the dose may be repeated after 6 to 8 hours, without exceeding a maximum daily dose of 1,200 mg of ibuprofen and 300 mg of caffeine, or 3 tablets per day.
Treatment should not last longer than 3 days.
Choose a lower dose of ibuprofen based on the severity of the pain
. IPRAFEINE 400 mg/100 mg film-coated tablets are not recommended for mild pain or when treatment lasts longer than 3 days.
In these situations, monotherapy at the minimum effective dose (for example, 200 mg of ibuprofen) should be considered.
For patients with a "sensitive" stomach, IPRAFEINE tablets should be taken with a meal.
Like other nonsteroidal anti-inflammatory drugs, ibuprofen is associated with adverse effects. The risk of these effects can be minimized by using the lowest effective dose for the shortest possible time necessary to relieve symptoms.
Pregnancy:
Unless absolutely necessary, this medication should not be used during the first and second trimesters of pregnancy. Its use is contraindicated during the third trimester (beyond 24 weeks of amenorrhea, i.e., 5 full months) due to the risk of premature closure of the ductus arteriosus with possible persistence of pulmonary hypertension.
Accidental use beyond 24 weeks of amenorrhea (5 full months) warrants cardiac, renal, fetal, and/or neonatal monitoring depending on the duration of exposure. The duration of this monitoring will be adjusted according to the elimination half-life of the molecule.
Breastfeeding:
Due to the presence of caffeine, IPRAFEINE 400 mg/100 mg film-coated tablets should be used by breastfeeding women only when absolutely necessary.
For moderate acute pain, the recommended dosage is 1 IPRAFEINE tablet (400 mg of ibuprofen and 100 mg of caffeine).
If necessary, the dose may be repeated after 6 to 8 hours, without exceeding a maximum daily dose of 1,200 mg of ibuprofen and 300 mg of caffeine, or 3 tablets per day.
Treatment should not last longer than 3 days.
Choose a lower dose of ibuprofen based on the severity of the pain
. IPRAFEINE 400 mg/100 mg film-coated tablets are not recommended for mild pain or when treatment lasts longer than 3 days.
In these situations, monotherapy at the minimum effective dose (for example, 200 mg of ibuprofen) should be considered.
For patients with a "sensitive" stomach, IPRAFEINE tablets should be taken with a meal.
Like other nonsteroidal anti-inflammatory drugs, ibuprofen is associated with adverse effects. The risk of these effects can be minimized by using the lowest effective dose for the shortest possible time necessary to relieve symptoms.
Pregnancy:
Unless absolutely necessary, this medication should not be used during the first and second trimesters of pregnancy. Its use is contraindicated during the third trimester (beyond 24 weeks of amenorrhea, i.e., 5 full months) due to the risk of premature closure of the ductus arteriosus with possible persistence of pulmonary hypertension.
Accidental use beyond 24 weeks of amenorrhea (5 full months) warrants cardiac, renal, fetal, and/or neonatal monitoring depending on the duration of exposure. The duration of this monitoring will be adjusted according to the elimination half-life of the molecule.
Breastfeeding:
Due to the presence of caffeine, IPRAFEINE 400 mg/100 mg film-coated tablets should be used by breastfeeding women only when absolutely necessary.
Chaque comprimé pelliculé contient 400 mg d’ibuprofène et 100 mg de caféine.
Pour la liste complète des excipients, voir la notice.
Pour la liste complète des excipients, voir la notice.
Log in 
